NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7 | -100.0% | 66,600 | -71.7% | 0.00% | -99.9% |
| Q3 2022 | $10,684,000 | +42.3% | 235,200 | +59.0% | 0.72% | +90.2% |
| Q2 2022 | $7,507,000 | -57.2% | 147,900 | -49.4% | 0.38% | -48.7% |
| Q1 2022 | $17,528,000 | +38.7% | 292,438 | +14.9% | 0.73% | +112.5% |
| Q4 2021 | $12,640,000 | +49.0% | 254,571 | +88.0% | 0.34% | +25.5% |
| Q3 2021 | $8,485,000 | +31.0% | 135,404 | +20.3% | 0.28% | +36.1% |
| Q2 2021 | $6,478,000 | +2.6% | 112,600 | -0.8% | 0.20% | -40.2% |
| Q1 2021 | $6,314,000 | +225.3% | 113,500 | +3.7% | 0.34% | +503.6% |
| Q4 2020 | $1,941,000 | -66.3% | 109,400 | +7.9% | 0.06% | -80.3% |
| Q3 2020 | $5,765,000 | +30.8% | 101,355 | +1.1% | 0.28% | +17.8% |
| Q2 2020 | $4,409,000 | +2478.4% | 100,291 | +79.7% | 0.24% | +2090.9% |
| Q1 2020 | $171,000 | +850.0% | 55,800 | +64.1% | 0.01% | +1000.0% |
| Q4 2019 | $18,000 | -10.0% | 34,005 | +87.8% | 0.00% | -50.0% |
| Q3 2019 | $20,000 | – | 18,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |